CN103145607A - Preparation process of 4-monosubstituted phenyl-1,2,3,6-tetrahydropyridine hydrochloride - Google Patents

Preparation process of 4-monosubstituted phenyl-1,2,3,6-tetrahydropyridine hydrochloride Download PDF

Info

Publication number
CN103145607A
CN103145607A CN2013100773931A CN201310077393A CN103145607A CN 103145607 A CN103145607 A CN 103145607A CN 2013100773931 A CN2013100773931 A CN 2013100773931A CN 201310077393 A CN201310077393 A CN 201310077393A CN 103145607 A CN103145607 A CN 103145607A
Authority
CN
China
Prior art keywords
phenyl
tetrahydropyridine hydrochloride
carboxylic acid
butyl ester
hydroxyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN2013100773931A
Other languages
Chinese (zh)
Other versions
CN103145607B (en
Inventor
袁玉坤
崔京南
王可为
郑玉斌
方文强
金耀博
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SUZHOU HANNA MATERIAL TECHNOLOGY CO LTD
Original Assignee
CHANGSHU RESEARCH INSTITUTE OF DLUT Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CHANGSHU RESEARCH INSTITUTE OF DLUT Co Ltd filed Critical CHANGSHU RESEARCH INSTITUTE OF DLUT Co Ltd
Priority to CN201310077393.1A priority Critical patent/CN103145607B/en
Publication of CN103145607A publication Critical patent/CN103145607A/en
Application granted granted Critical
Publication of CN103145607B publication Critical patent/CN103145607B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Hydrogenated Pyridines (AREA)

Abstract

The invention discloses a preparation process of 4-monosubstituted phenyl-1,2,3,6-tetrahydropyridine hydrochloride. The process comprises the following steps of: reacting N-tert-butyloxycarboryl-4-piperidone with a substituted phenyl Grignard reagent to prepare tert-butyl 4-hydroxy-4-monosubstituted phenyl piperidine-1-carboxylate; and then, acidizing by hydrochloric acid, removing Boc, salifying, dehydrating in molecules, cooling and filtering to obtain the target product 4-monosubstituted phenyl-1,2,3,6-tetrahydropyridine hydrochloride. The preparation method is reasonable in line, high in yield, high in purity, simple and easily-available in raw materials, low in cost and suitable for industrial massive production.

Description

4-monosubstituted phenyl-1,2,3, the preparation technology of 6-tetrahydropyridine hydrochloride
Technical field
The invention belongs to the Synthetic Organic Chemistry field, relate to a kind of 4-monosubstituted phenyl-1,2,3, the preparation technology of 6-tetrahydropyridine hydrochloride.
Background technology
4-substituted-phenyl-1,2,3,6-tetrahydropyridine hydrochloride is a kind of important medicine and pesticide intermediate, is widely used in medicine and agricultural chemicals production, has larger industrial prospect and social benefit, its chemical structural formula is as follows:
Figure 2013100773931100002DEST_PATH_IMAGE002
Wherein R represents hydrogen, fluorine, chlorine, bromine, methyl, trifluoromethyl, methoxyl group.
Bibliographical information synthesizes 4-substituted-phenyl-1,2,3 at present, and the method for 6-tetrahydropyridine hydrochloride mainly contains two kinds.Adopt the reaction of N-benzyl-4-piperidone and phenyl-magnesium-bromide, then slough benzyl by methylsulphonic acid, then change into hydrochloride and obtain target compound (Bioorg. Med. Chem. Lett., 22 (2012), 2560.).This synthetic method shortcoming is that reactions steps is long, and total recovery is lower than 50.0%, and aftertreatment produces a large amount of waste water.For example, adopt phenylo boric acid and N-tertbutyloxycarbonyl-4-trifluoromethanesulfonic acid base-1,2,3,6 tetrahydropyridines are raw material, through the suzuki linked reaction, the intermediate product that obtains is sloughed tertbutyloxycarbonyl under the hydrochloric acid effect, obtains 4-substituted-phenyl-1 after salify, 2,3,6-tetrahydropyridine hydrochloride (Bioorg. Med. Chem. Lett., 13 (2003) 3951.).The shortcoming of this synthetic method is that starting raw material is expensive, and uses expensive catalyzer, easily causes heavy metal contamination.
Summary of the invention
The present invention has avoided the shortcoming of above two kinds of methods, and raw material is cheap and easy to get, and synthetic route is simple, and total recovery is avoided environment is caused severe contamination up to more than 80.0%.Its reaction process is as follows:
Figure 2013100773931100002DEST_PATH_IMAGE004
The purpose of this invention is to provide a kind of 4-monosubstituted phenyl-1,2,3, the preparation technology of 6-tetrahydropyridine hydrochloride.
Realize that the technical scheme that the object of the invention is taked is: a kind of 4-monosubstituted phenyl-1,2,3, the preparation technology of 6-tetrahydropyridine hydrochloride comprises the following steps:
1) preparation of 4-hydroxyl-4-R substituted phenylpiperidines-1-carboxylic acid tert-butyl ester:
N-tertbutyloxycarbonyl-4-piperidone is dissolved in tetrahydrofuran (THF), cool to-5~15 ℃, be added dropwise to R substituted-phenyl magnesium bromide, stirred 3~8 hours at 10~15 ℃, after having reacted, add the hydrochloric acid cancellation to be neutrality, extraction to the pH value, organic phase is replaced as Virahol, obtains the aqueous isopropanol of 4-hydroxyl-4-R Phenylpiperidine-1-carboxylic acid tert-butyl ester;
2) 4-monosubstituted phenyl-1,2,3, the preparation of 6-tetrahydropyridine hydrochloride:
Aqueous isopropanol at 4-hydroxyl-4-R substituted phenylpiperidines-1-carboxylic acid tert-butyl ester passes into hydrogen chloride gas, stirs to heat up, and 75~82 ℃ of reactions 1~10 hour, after having reacted, is cooled to 10~20 ℃, stirs 1~5 hour, filters, and gets target product.
R substituted-phenyl described in step 1 is hydrogen, fluorine, chlorine, bromine, methyl, trifluoromethyl or methoxyl group.
The concentration of hydrochloric acid of the cancellation process using described in step 1 is 1.0 ~ 12.0mol/L, and ethyl acetate, 2-methyltetrahydrofuran, t-butyl methyl ether or toluene are adopted in described extraction.
Mol ratio 1.2 ~ the 1.5:1 of the N-tertbutyloxycarbonyl described in step 1-4-piperidone and R substituted-phenyl magnesium bromide.
Mol ratio 3.0 ~ the 5.0:1 of the 4-hydroxyl described in step 2-4-R substituted phenylpiperidines-1-carboxylic acid tert-butyl ester and hydrogen chloride gas.
Compared with prior art, the present invention has avoided the shortcoming of two kinds of methods of prior art, and raw material is cheap and easy to get, and synthetic route is simple, and total recovery is avoided environment is caused severe contamination up to more than 80.0%.
Embodiment
Embodiment 1.
4-phenyl-1,2,3, the preparation technology of 6-tetrahydropyridine hydrochloride
1) preparation of 4-hydroxy-4-phenyl piperidine-1-carboxylic acid tert-butyl ester
in the reaction flask of 30.0 L, be equipped with mechanical stirring, nitrogen protection, the constant pressure funnel device, add 2.2 kg N-tertbutyloxycarbonyl-4-piperidone, with 6.6 L tetrahydrofuran solvents, cool to-5~0 ℃, drip the solution that 3.0 Kg phenyl-magnesium-bromides are dissolved in 5.0 L tetrahydrofuran (THF)s, stirred 3 hours at-5~0 ℃, HPLC analyzes and shows without raw material, at the about 18.0L of the hydrochloric acid that drips 1.0mol/L below 30 ℃, be neutral to pH, add 5.0 L ethyl acetate, extraction, separatory, organic phase is threaded to 3.0 L, add 7.0 L Virahols, organic phase is threaded to 5.0 L, namely get the aqueous isopropanol of 4-hydroxy-4-phenyl piperidine-1-carboxylic acid tert-butyl ester.
2) 4-phenyl-1,2,3, the preparation of 6-tetrahydropyridine hydrochloride
In the reaction flask of 30.0 L, add the aqueous isopropanol of above-mentioned 4-hydroxy-4-phenyl piperidine-1-carboxylic acid tert-butyl ester.Be cooled to 10~20 ℃, pass into 2.0 kg hydrogen chloride gas, be warming up to 75~82 ℃ of reactions 10 hours, HPLC analyzes and shows without raw material, be cooled to 10~20 ℃, stirred 2 hours, filter, obtain faint yellow solid, yield 85.2%, purity 99.6%, nuclear-magnetism H spectrum identifies that structure is correct.
Embodiment 2.
4-(4-fluorophenyl)-1,2,3, the preparation technology of 6-tetrahydropyridine hydrochloride
1) preparation of 4-hydroxyl-4-(4-fluorophenyl)-1-carboxylic acid tert-butyl ester
in the reaction flask of 30.0 L, be equipped with mechanical stirring, nitrogen protection, the constant pressure funnel device, add 2.0 kg N-tertbutyloxycarbonyl-4-piperidone, with 6.6 L tetrahydrofuran solvents, cool to 0~5 ℃, drip the solution that 2.6 Kg 4-fluorophenyl magnesium bromides are dissolved in 4.0 L tetrahydrofuran (THF)s, stirred 5 hours at 0~5 ℃, HPLC analyzes and shows without raw material, at about 8.0 L of the hydrochloric acid that drips 3.0 mol/L below 30 ℃, be neutral to pH, add 5.0 L 2-methyltetrahydrofurans, extraction, separatory, organic phase is threaded to 3.0 L, add 7.0 L Virahols, organic phase is threaded to 6.0 L, namely get the aqueous isopropanol of 4-hydroxyl-4-(4-fluorophenyl) piperidines-1-carboxylic acid tert-butyl ester.
2) 4-(4-fluorophenyl)-1,2,3, the preparation of 6-tetrahydropyridine hydrochloride
In the reaction flask of 30.0 L, add the aqueous isopropanol of above-mentioned 4-hydroxyl-4-(4-fluorophenyl) piperidines-1-carboxylic acid tert-butyl ester.Be cooled to 10~20 ℃, pass into 1.1 kg hydrogen chloride gas, be warming up to 75~82 ℃ of reactions 8 hours, HPLC analyzes and shows without raw material, be cooled to 10~20 ℃, stirred 2 hours, filter, obtain faint yellow solid, yield 88.5%, purity 99.6%, nuclear-magnetism H spectrum identifies that structure is correct.
Embodiment 3.
4-(4-chloro-phenyl-)-1,2,3, the preparation technology of 6-tetrahydropyridine hydrochloride
1) preparation of 4-hydroxyl-4-(4-chloro-phenyl-)-1-carboxylic acid tert-butyl ester
in the reaction flask of 30.0 L, be equipped with mechanical stirring, nitrogen protection, the constant pressure funnel device, add 2.0 kg N-tertbutyloxycarbonyl-4-piperidone, with 6.6 L tetrahydrofuran solvents, cool to 0~5 ℃, drip the solution that 3.0 Kg 4-chloro-phenyl-magnesium bromides are dissolved in 6.0 L tetrahydrofuran (THF)s, stirred 7 hours at 0~5 ℃, HPLC analyzes and shows without raw material, at about 4 L of the hydrochloric acid that drips 6.0 mol/L below 30 ℃, be neutral to pH, add 5.0 L ethyl acetate, extraction, separatory, organic phase is threaded to 2.0 L, add 8.0 L Virahols, organic phase is threaded to 6.0 L, namely get the aqueous isopropanol of 4-hydroxyl-4-(4-chloro-phenyl-) piperidines-1-carboxylic acid tert-butyl ester.
2) 4-(4-chloro-phenyl-)-1,2,3, the preparation of 6-tetrahydropyridine hydrochloride
In the reaction flask of 30.0 L, add the aqueous isopropanol of above-mentioned 4-hydroxyl-4-(4-chloro-phenyl-) piperidines-1-carboxylic acid tert-butyl ester.Be cooled to 10~20 ℃, pass into 1.5 kg hydrogen chloride gas, be warming up to 75~82 ℃ of reactions 7 hours, HPLC analyzes and shows without raw material, be cooled to 10~20 ℃, stirred 2 hours, filter, obtain faint yellow solid, yield 89.0%, purity 99.3%, nuclear-magnetism H spectrum identifies that structure is correct.
Embodiment 4.
4-(4-bromophenyl)-1,2,3, the preparation technology of 6-tetrahydropyridine hydrochloride
1) preparation of 4-hydroxyl-4-(4-bromophenyl)-1-carboxylic acid tert-butyl ester
in the reaction flask of 30.0 L, be equipped with mechanical stirring, nitrogen protection, the constant pressure funnel device, add 1.8 kg N-tertbutyloxycarbonyl-4-piperidone, with 6.6 L tetrahydrofuran solvents, cool to 10~15 ℃, drip the solution that 3.5 Kg 4-fluorophenyl magnesium bromides are dissolved in 6.0 L tetrahydrofuran (THF)s, stirred 6 hours at 10~15 ℃, HPLC analyzes and shows without raw material, at about 5.0 L of the hydrochloric acid that drips 4.0 mol/L below 30 ℃, be neutral to pH, add 5.0 L ethyl acetate, extraction, separatory, organic phase is threaded to 3.0 L, add 9.0 L Virahols, organic phase is threaded to 5.0 L, namely get the aqueous isopropanol of 4-hydroxyl-4-(4-bromophenyl) piperidines-1-carboxylic acid tert-butyl ester.
2) 4-(4-bromophenyl)-1,2,3, the preparation of 6-tetrahydropyridine hydrochloride
In the reaction flask of 30.0 L, add the aqueous isopropanol of above-mentioned 4-hydroxyl-4-(4-bromophenyl) piperidines-1-carboxylic acid tert-butyl ester.Be cooled to 10~20 ℃, pass into 1.3 kg hydrogen chloride gas, be warming up to 75~82 ℃ of reactions 3 hours, HPLC analyzes and shows without raw material, be cooled to 10~20 ℃, stirred 2 hours, filter, obtain faint yellow solid, yield 81.6%, purity 99.2%, nuclear-magnetism H spectrum identifies that structure is correct.
Embodiment 5.
4-(4-aminomethyl phenyl)-1,2,3, the preparation technology of 6-tetrahydropyridine hydrochloride
1) preparation of 4-hydroxyl-4-(4-aminomethyl phenyl)-1-carboxylic acid tert-butyl ester
in the reaction flask of 30.0 L, be equipped with mechanical stirring, nitrogen protection, the constant pressure funnel device, add 2.0 kg N-tertbutyloxycarbonyl-4-piperidone, with 6.6 L tetrahydrofuran solvents, cool to 5~10 ℃, drip the solution that 2.7 Kg 4-aminomethyl phenyl magnesium bromides are dissolved in 5.0 L tetrahydrofuran (THF)s, stirred 8 hours at 5~10 ℃, HPLC analyzes and shows without raw material, at about 12.0 L of the hydrochloric acid that drips 2.0 mol/L below 30 ℃, be neutral to pH, add 5.0 L t-butyl methyl ether, extraction, separatory, organic phase is threaded to 2.0 L, add 7.0 L Virahols, organic phase is threaded to 6.0 L, namely get the aqueous isopropanol of 4-hydroxyl-4-(4-aminomethyl phenyl) piperidines-1-carboxylic acid tert-butyl ester.
2) 4-(4-aminomethyl phenyl)-1,2,3, the preparation of 6-tetrahydropyridine hydrochloride
In the reaction flask of 30.0 L, add the aqueous isopropanol of above-mentioned 4-hydroxyl-4-(4-aminomethyl phenyl) piperidines-1-carboxylic acid tert-butyl ester.Be cooled to 10~20 ℃, pass into the 1.8kg hydrogen chloride gas, be warming up to 75~82 ℃ of reactions 5 hours, HPLC analyzes and shows without raw material, be cooled to 10~20 ℃, stirred 2 hours, filter, obtain faint yellow solid, yield 85.3%, purity 99.8%, nuclear-magnetism H spectrum identifies that structure is correct.
Embodiment 6.
4-(4-trifluoromethyl)-1,2,3, the preparation technology of 6-tetrahydropyridine hydrochloride
1) preparation of 4-hydroxyl-4-(4-trifluoromethyl)-1-carboxylic acid tert-butyl ester
in the reaction flask of 30.0 L, be equipped with mechanical stirring, nitrogen protection, the constant pressure funnel device, add 1.9 kg N-tertbutyloxycarbonyl-4-piperidone, with 6.6 L tetrahydrofuran solvents, cool to 10~15 ℃, drip the solution that 3.0 Kg 4-trifluoromethyl magnesium bromides are dissolved in 5.0 L tetrahydrofuran (THF)s, stirred 4 hours at 10~15 ℃, HPLC analyzes and shows without raw material, at about 11.0 L of the hydrochloric acid that drips 2.0 mol/L below 30 ℃, be neutral to pH, add 6.0 L toluene, extraction, separatory, organic phase is threaded to 2.0 L, add 7.0 L Virahols, organic phase is threaded to 5.0 L, namely get the aqueous isopropanol of 4-hydroxyl-4-(4-trifluoromethyl) piperidines-1-carboxylic acid tert-butyl ester.
2) 4-(4-trifluoromethyl)-1,2,3, the preparation of 6-tetrahydropyridine hydrochloride
In the reaction flask of 30.0 L, add the aqueous isopropanol of above-mentioned 4-hydroxyl-4-(4-trifluoromethyl) piperidines-1-carboxylic acid tert-butyl ester.Be cooled to 10~20 ℃, pass into 1.7 kg hydrogen chloride gas, be warming up to 75~82 ℃ of reactions 6 hours, HPLC analyzes and shows without raw material, be cooled to 10~20 ℃, stirred 3 hours, filter, obtain faint yellow solid, yield 80.5%, purity 99.0%, nuclear-magnetism H spectrum identifies that structure is correct.
Embodiment 7.
4-(4-p-methoxy-phenyl)-1,2,3, the preparation technology of 6-tetrahydropyridine hydrochloride
1) preparation of 4-hydroxyl-4-(4-p-methoxy-phenyl)-1-carboxylic acid tert-butyl ester
in the reaction flask of 30.0 L, be equipped with mechanical stirring, nitrogen protection, the constant pressure funnel device, add 2.1 kg N-tertbutyloxycarbonyl-4-piperidone, with 6.6 L tetrahydrofuran solvents, cool to-5~0 ℃, drip the solution that 3.3 Kg 4-p-methoxy-phenyl magnesium bromides are dissolved in 4.0 L tetrahydrofuran (THF)s, stirred 8 hours at-5~0 ℃, HPLC analyzes and shows without raw material, at about 1.2 L of the hydrochloric acid that drips 12.0 mol/L below 30 ℃, be neutral to pH, add 5.5 L ethyl acetate, extraction, separatory, organic phase is threaded to 2.0 L, add 9.0 L Virahols, organic phase is threaded to 5.0 L, namely get the aqueous isopropanol of 4-hydroxyl-4-(4-p-methoxy-phenyl) piperidines-1-carboxylic acid tert-butyl ester.
2) 4-(4-p-methoxy-phenyl)-1,2,3, the preparation of 6-tetrahydropyridine hydrochloride
In the reaction flask of 30.0 L, add the aqueous isopropanol of above-mentioned 4-hydroxyl-4-(4-p-methoxy-phenyl) piperidines-1-carboxylic acid tert-butyl ester.Be cooled to 10~20 ℃, pass into 1.2 kg hydrogen chloride gas, be warming up to 75~82 ℃ of reactions 2 hours, HPLC analyzes and shows without raw material, be cooled to 10~20 ℃, stirred 1 hour, filter, obtain faint yellow solid, yield 85.0%, purity 99.5%, nuclear-magnetism H spectrum identifies that structure is correct.

Claims (5)

1. 4-monosubstituted phenyl-1,2,3, the preparation technology of 6-tetrahydropyridine hydrochloride is characterized in that described technique comprises the following steps:
1) preparation of 4-hydroxyl-4-R substituted phenylpiperidines-1-carboxylic acid tert-butyl ester:
N-tertbutyloxycarbonyl-4-piperidone is dissolved in tetrahydrofuran (THF), cool to-5~15 ℃, be added dropwise to R substituted-phenyl magnesium bromide, stirred 3~8 hours at 10~15 ℃, after having reacted, add the hydrochloric acid cancellation to be neutrality, extraction to the pH value, organic phase is replaced as Virahol, obtains the aqueous isopropanol of 4-hydroxyl-4-R Phenylpiperidine-1-carboxylic acid tert-butyl ester;
2) 4-monosubstituted phenyl-1,2,3, the preparation of 6-tetrahydropyridine hydrochloride:
Aqueous isopropanol at 4-hydroxyl-4-R substituted phenylpiperidines-1-carboxylic acid tert-butyl ester passes into hydrogen chloride gas, stirs to heat up, and 75~82 ℃ of reactions 1~10 hour, after having reacted, is cooled to 10~20 ℃, stirs 1~5 hour, filters, and gets target product.
2. 4-monosubstituted phenyl-1,2,3 according to claim 1, the preparation technology of 6-tetrahydropyridine hydrochloride is characterized in that the R substituted-phenyl described in step 1 is hydrogen, fluorine, chlorine, bromine, methyl, trifluoromethyl or methoxyl group.
3. 4-monosubstituted phenyl-1 according to claim 1,2,3, the preparation technology of 6-tetrahydropyridine hydrochloride, the concentration of hydrochloric acid that it is characterized in that the cancellation process using described in step 1 is 1.0 ~ 12.0mol/L, and ethyl acetate, 2-methyltetrahydrofuran, t-butyl methyl ether or toluene are adopted in described extraction.
4. 4-monosubstituted phenyl-1,2,3 according to claim 1, the preparation technology of 6-tetrahydropyridine hydrochloride is characterized in that the mol ratio 1.2 ~ 1.5:1 of the N-tertbutyloxycarbonyl described in step 1-4-piperidone and R substituted-phenyl magnesium bromide.
5. 4-monosubstituted phenyl-1,2,3 according to claim 1, the preparation technology of 6-tetrahydropyridine hydrochloride is characterized in that the mol ratio 3.0 ~ 5.0:1 of the 4-hydroxyl described in step 2-4-R substituted phenylpiperidines-1-carboxylic acid tert-butyl ester and hydrogen chloride gas.
CN201310077393.1A 2013-03-12 2013-03-12 Preparation process of 4-monosubstituted phenyl-1,2,3,6-tetrahydropyridine hydrochloride Active CN103145607B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201310077393.1A CN103145607B (en) 2013-03-12 2013-03-12 Preparation process of 4-monosubstituted phenyl-1,2,3,6-tetrahydropyridine hydrochloride

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201310077393.1A CN103145607B (en) 2013-03-12 2013-03-12 Preparation process of 4-monosubstituted phenyl-1,2,3,6-tetrahydropyridine hydrochloride

Publications (2)

Publication Number Publication Date
CN103145607A true CN103145607A (en) 2013-06-12
CN103145607B CN103145607B (en) 2015-07-01

Family

ID=48543988

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201310077393.1A Active CN103145607B (en) 2013-03-12 2013-03-12 Preparation process of 4-monosubstituted phenyl-1,2,3,6-tetrahydropyridine hydrochloride

Country Status (1)

Country Link
CN (1) CN103145607B (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5929663A (en) * 1982-08-13 1984-02-16 Mitsui Petrochem Ind Ltd 4-(2,4-dihydroxyphenyl)-3,4-dehydropiperidine compound and its preparation
CN101696187A (en) * 2009-09-30 2010-04-21 徐州工业职业技术学院 Synthesizing method of N-substituent-1,2,3,6-tetrahydropyridine

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5929663A (en) * 1982-08-13 1984-02-16 Mitsui Petrochem Ind Ltd 4-(2,4-dihydroxyphenyl)-3,4-dehydropiperidine compound and its preparation
CN101696187A (en) * 2009-09-30 2010-04-21 徐州工业职业技术学院 Synthesizing method of N-substituent-1,2,3,6-tetrahydropyridine

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
RICHARD J. CONWAY,等: ""Synthesis and SAR study of 4-arylpiperidines and 4-aryl-1,2,3,6-tetrahydropyridines as 5-HT2C agonists"", 《BIOORGANIC & MEDICINAL CHEMISTRY LETTERS》 *
李敬芬,等: "《药物合成反应》", 31 August 2010 *

Also Published As

Publication number Publication date
CN103145607B (en) 2015-07-01

Similar Documents

Publication Publication Date Title
CN105367557B (en) A kind of preparation method of epoxy quinoline
CN103641722B (en) A kind of production method of adjacent nitro bromobenzyl
CN104530106A (en) Method for preparing arylboronic acid compound
CN102070575A (en) New synthesis method of caronic anhydride
CN103833560A (en) Preparation method of (S)-5-chloro-alpha-cyclopropinyl-2-amino-alpha-trifluoromethyl phenylcarbinol
CN113475739B (en) Preparation method of S-nicotine
CN102584694A (en) Preparation methods for important intermediates of anthranilic diamide compound
CN103145607B (en) Preparation process of 4-monosubstituted phenyl-1,2,3,6-tetrahydropyridine hydrochloride
CN103360330A (en) Synthetic method for homopiperazine
CN107501277B (en) A kind of furanone and the synthetic method for hydrogenating azepines compound
CN105348044B (en) A kind of synthetic method of hemlock extract (S)-Virol A
CN110483274A (en) A kind of preparation method of cyclopentolate hydrochloride intermediate
CN101805315B (en) Synthesis method of ethyl tetrahydrofurfuryl ether
CN103664675A (en) Method for preparing 2-chloro-N-(4-fluorophenyl)-N-isopropylacetamide
CN110003023B (en) Preparation method of environment-friendly N, N-dimethylformamide dimethyl acetal
CN104086475B (en) A kind of preparation method of N-benzyloxycarbonyl group-L-prolineamide
CN106946724A (en) The synthetic method of the benzyl malonic acid mono ethyl ester of 2 acetylamino of monoamine base inhibitor class intermediate 2
CN105037239B (en) A kind of preparation method of the acetic acid of 4 chloro-indole 3
CN103214413B (en) Heterocycle-containing trifluoromethyl ketone compound and preparation method thereof
CN105753804A (en) Method of preparing 3-morpholinone
CN104030906A (en) Method for preparing 9-fluorenone by liquid-phase oxidation
CN111533689A (en) 2, 2' -biquinoline compound and one-pot preparation method thereof
CN105061375A (en) Method for preparing 3-isochromanone
CN100430403C (en) 3-aryl-5,6-substituted thienopyrimidine-4-carbonyl-2-mercaptoacetonitrile, and its synthesizing method and use
CN102757399B (en) Preparation method of aliskiren intermediate

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
TR01 Transfer of patent right
TR01 Transfer of patent right

Effective date of registration: 20240409

Address after: 215500 No. 7, research institute road, Bixi street, Changshu, Suzhou, Jiangsu

Patentee after: Suzhou Hanna Material Technology Co.,Ltd.

Country or region after: China

Address before: No. 9 Research Institute Road, Science and Technology Innovation Park, Changshu Economic and Technological Development Zone, Suzhou City, Jiangsu Province, 215500

Patentee before: CHANGSHU RESEARCH INSTITUTE OF DLUT Co.,Ltd.

Country or region before: China